ATRECA INC's ticker is BCEL and the CUSIP is 04965G109. A total of 111 filers reported holding ATRECA INC in Q2 2021. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $84 | -13.4% | 85 | 0.0% | 0.00% | – |
| Q1 2023 | $97 | +42.6% | 85 | 0.0% | 0.00% | – |
| Q4 2022 | $68 | – | 85 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 85 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 85 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 85 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 85 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 85 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | – | 85 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,396,644 | $23,000,000 | 5.25% |
| EcoR1 Capital, LLC | 2,426,685 | $39,191,000 | 2.11% |
| Boxer Capital, LLC | 2,202,333 | $35,568,000 | 1.14% |
| Aisling Capital Management LP | 387,653 | $6,261,000 | 1.08% |
| CM Management, LLC | 60,000 | $969,000 | 0.90% |
| Samsara BioCapital, LLC | 474,943 | $7,670,000 | 0.77% |
| Parkman Healthcare Partners LLC | 126,258 | $2,039,000 | 0.52% |
| Redmile Group, LLC | 2,476,068 | $39,988,000 | 0.48% |
| Sio Capital Management, LLC | 128,455 | $2,075,000 | 0.42% |
| HighVista Strategies LLC | 30,824 | $498,000 | 0.32% |